1. A randomized, double‐blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive‐stage small cell lung cancer: Hoosier Cancer Research Network LUN06‐113. Issue 2 (1st September 2016) Authors: Sanborn, Rachel E.; Patel, Jyoti D.; Masters, Gregory A.; Jayaram, Nagesh; Stephens, Anthony; Guarino, Michael; Misleh, Jamal; Wu, Jingwei; Hanna, Nasser Journal: Cancer Issue: Volume 123:Issue 2(2017) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient survey. Issue 14 (20th April 2022) Authors: Ligibel, Jennifer A.; Pierce, Lori J.; Bender, Catherine M.; Crane, Tracy E.; Dieli‐Conwright, Christina; Hopkins, Judith O.; Masters, Gregory A.; Schenkel, Caroline; Garrett‐Mayer, Elizabeth; Katta, Sweatha; Merrill, Janette K.; Salamone, Jeannine M.; Brewster, Abenaa M. Journal: Cancer Issue: Volume 128:Issue 14(2022) Page Start: 2817 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non–small‐cell lung cancer. (14th June 2018) Authors: Laslett, Nicole F.; Park, SuJung; Masters, Gregory A.; Biggs, David D.; Schneider, Charles J.; Misleh, Jamal G.; Suppiah, Kathir; Simpson, Pamela S.; Grubbs, Stephen; Wozniak, Timothy F.; Guarino, Michael Journal: Cancer medicine Issue: Volume 7:Number 7(2018:Jul.) Page Start: 2969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Progress in lung cancer: ASCO 2015. (December 2015) Authors: Masters, Gregory A. Journal: Surgical oncology Issue: Volume 24:Number 4(2015) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study. Issue 12 (December 2016) Authors: Pujol, Jean‐Louis; De Pas, Tommaso; Rittmeyer, Achim; Vallières, Eric; Kubisa, Bartosz; Levchenko, Eugeny; Wiesemann, Sebastian; Masters, Gregory A.; Shen, Robert; Tjulandin, Sergei A.; Hofmann, Hans‐Stefan; Vanhoutte, Nicolas; Salaun, Bruno; Debois, Muriel; Jarnjak, Silvija; De Sousa Alves, Pedr... Journal: Journal of thoracic oncology Issue: Volume 11:Issue 12(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538. (June 2021) Authors: Bogart, Jeffrey A.; Wang, Xiaofei; Masters, Gregory A.; Gao, Junheng; Komaki, Ritsuko; Gaspar, Laurie E.; Heymach, John V.; Dobelbower, Michael Christian; Kuzma, Charles; Stinchcombe, Thomas E.; Vokes, Everett E. Journal: Lung cancer Issue: Volume 156(2021) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗